[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100304832":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":13,"studyPopulation":17,"armGroups":18,"interventions":27,"overallOfficials":33,"centralContacts":37,"locations":45,"responsibleParty":85,"collaborators":13,"id":87,"slug":88,"hasResults":89,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":13,"eligibilityCriteria":93,"healthyVolunteers":89,"sex":94,"minAge":95,"maxAge":96,"enrollmentInfo":97,"targetDuration":13,"studyType":100,"phases":13,"briefSummary":101,"conditions":102,"keywords":104,"overallStatus":48,"whyStopped":13,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"Memorial Sloan Kettering Cancer Center","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Quality of Life","Questionnaire to assess quality of life changes","up to 40 months",null,{"allocation":13,"interventionModel":13,"interventionModelDescription":13,"primaryPurpose":13,"observationalModel":15,"timePerspective":16,"maskingInfo":13},"CASE_CONTROL","PROSPECTIVE","Patients who present for consultation of their lymphedema and who meet eligibility criteria will be offered the option of enrolling in this study at the time of their initial consultation.",[19,24],{"label":20,"type":13,"description":21,"interventionNames":22},"vascularized lymph node transfer (VLNT)","This is an observational study to assess QOL in patients who have elected to undergo or considered undergoing VLNT. There is no therapeutic intervention involved during the follow-up study period.",[23],"Behavioral: Quality of Life Assessments",{"label":25,"type":13,"description":21,"interventionNames":26},"non-surgical treatment",[23],[28],{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":13},"BEHAVIORAL","Quality of Life Assessments","Upper Limb Lymphedema (ULL-27), Lymphedema Life Impact Scale, version 2 (LLISv2), LYMQOL-Leg.",[25,20],[34],{"name":35,"affiliation":5,"role":36},"Babak Mahrara, MD","PRINCIPAL_INVESTIGATOR",[38,42],{"name":35,"role":39,"phone":40,"phoneExt":13,"email":41},"CONTACT","646-608-8085","mehrarab@MSKCC.ORG",{"name":43,"role":39,"phone":44,"phoneExt":13,"email":13},"Andrea Barrio, MD","646-888-5118",[46,63,73],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Memorial Sloan Kettering Westchester (Limited Protocol Activities)","RECRUITING","Harrison","New York","10604","United States","US",{"type":55,"coordinates":56},"Point",[57,58],-73.71263,40.96899,{"lat":58,"lon":57},[61,62],{"name":35,"role":39,"phone":40,"phoneExt":13,"email":13},{"name":43,"role":39,"phone":44,"phoneExt":13,"email":13},{"facility":5,"status":48,"city":50,"state":50,"zip":64,"country":52,"countryCode":53,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"10065",{"type":55,"coordinates":66},[67,68],-74.00597,40.71427,{"lat":68,"lon":67},[71,72],{"name":35,"role":39,"phone":40,"phoneExt":13,"email":13},{"name":43,"role":39,"phone":44,"phoneExt":13,"email":13},{"facility":74,"status":48,"city":75,"state":50,"zip":76,"country":52,"countryCode":53,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Memorial Sloan Kettering Nassau (Limited Protocol Activites)","Rockville Centre","11553",{"type":55,"coordinates":78},[79,80],-73.64124,40.65871,{"lat":80,"lon":79},[83],{"name":84,"role":39,"phone":40,"phoneExt":13,"email":13},"Babak Mahrara, PhD",{"type":86,"investigatorFullName":13,"investigatorTitle":13,"investigatorAffiliation":13,"oldNameTitle":13,"oldOrganization":13},"SPONSOR","100304832","a-study-comparing-quality-of-life-in-patients-with-lymphedema-who-undergo-surgical-treatment-versus-non-surgical-management-100304832",false,"NCT03248310","A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management","A Prospective Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management","Inclusion Criteria:\n\n* Patients aged 18-80 years\n* Primary and secondary lymphedema of the upper or lower extremity\n* International Society of Lymphology (ISL) Stage 1, 2, or 3 lymphedema\n* Proficiency in English language\n\nExclusion Criteria:\n\n* Patients with clotting disorders, venous insufficiency, end-stage lymphedema unless they are on the non-surgical arm.\n* Additionally, if the patient refuses to complete questionnaires, the patient will be excluded from the study and replaced at the discretion of the principal or co-principal investigator.","ALL","18 Years","80 Years",{"count":98,"type":99},600,"ESTIMATED","OBSERVATIONAL","This study is being done to see the long-term results for patients who choose to have surgery for lymphedema (with the vascularized lymph node transfer), compared to patients who choose not to have surgery.",[103],"Lymphedema",[105,106],"Quality of Life (QoL)","17-377","2026-09-21",{"date":109,"type":110},"2026-09-24","ACTUAL",{"date":112,"type":110},"2017-08-09",{"date":114,"type":99},"2027-08",{"name":5,"class":6},3]